Zentalis Pharmaceuticals, Inc. (ZNTL)
USD 2.92
(-6.87%)
USD 2.92
(-6.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -207.82 Million | -163.75 Million | -154.09 Million | -86.82 Million | -39.14 Million | -24.25 Million |
| Net Income | -292.19 Million | -237.11 Million | -166.09 Million | -118.54 Million | -46.37 Million | -23.43 Million |
| Depreciation & Amortization | 1.38 Million | 1.42 Million | 544 Thousand | 160 Thousand | 111 Thousand | 51 Thousand |
| Deferred income taxes | -853 Thousand | -769 Thousand | -2.46 Million | 17 Thousand | 7.77 Million | 2.36 Million |
| Stock-based compensation | 54.82 Million | 46.84 Million | 35.73 Million | 23.14 Million | 617 Thousand | 308 Thousand |
| Change in working capital | 5.86 Million | 13.25 Million | 16.55 Million | 7.84 Million | 6.5 Million | -1.17 Million |
| Other non-cash items | 23.14 Million | 12.61 Million | -38.37 Million | 556 Thousand | -7.77 Million | -2.36 Million |
| Investing Cash Flow | -44.45 Million | -114.18 Million | -18.11 Million | -284.83 Million | -352 Thousand | -227 Thousand |
| Investments in PPE | -583 Thousand | -2.54 Million | -6.1 Million | -758 Thousand | -352 Thousand | -227 Thousand |
| Acquisitions | 43.87 Thousand | 111.63 Thousand | -14.32 Million | 18.42 Million | - | - |
| Investment purchases | -549.18 Million | -533.16 Million | -363.5 Million | -400.98 Million | - | - |
| Sales/Maturities of investments | 505.3 Million | 421.52 Million | 365.82 Million | 116.91 Million | - | - |
| Other Investing Activities | -43.87 Thousand | -111.63 Thousand | -12 Thousand | -18.42 Million | - | - |
| Financing Cash Flow | 237.3 Million | 261.04 Million | 178.52 Million | 360.43 Million | 81.83 Million | 9.47 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1146.00 | - | - | - |
| Common Stock Issuance | 237.3 Million | 261.04 Million | 179.66 Million | 327.78 Million | 81.83 Million | 16 Thousand |
| Other Financing Activities | 237.3 Million | 261.04 Thousand | -1.14 Million | 32.65 Million | -46 Thousand | 9.45 Million |
| Accounts receivables | - | - | 413 Thousand | -277 Thousand | 777 Thousand | -254 Thousand |
| Accounts payables | 10.91 Million | 15.52 Million | 13.91 Million | 14.3 Million | 7.12 Million | 977 Thousand |
| Inventory | - | - | 881 Thousand | -5.51 Million | -1.5 Million | -1.86 Million |
| Other working capital | -5.05 Million | -2.27 Million | 1.34 Million | -667 Thousand | 115 Thousand | -40 Thousand |
| Cash at beginning of period | 43.06 Million | 62.58 Million | 56.27 Million | 67.48 Million | 25.15 Million | 40.16 Million |
| Cash at end of period | 28.03 Million | 45.69 Million | 62.58 Million | 56.27 Million | 67.48 Million | 25.15 Million |
| Capital Expenditure | -583 Thousand | -2.54 Million | -6.1 Million | -758 Thousand | -352 Thousand | -227 Thousand |
| Effect of forex changes on cash | -54 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -15.03 Million | -16.88 Million | 6.31 Million | -11.21 Million | 42.33 Million | -15 Million |
| Free Cash Flow | -208.4 Million | -166.29 Million | -160.2 Million | -87.58 Million | -39.49 Million | -24.47 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -88.27 Million | 10.06 Million | -60.91 Million | -292.19 Million | -55.54 Million | -112.56 Million |
| Depreciation & Amortization | 327 Thousand | 324 Thousand | 337 Thousand | 1.38 Million | 348 Thousand | 344 Thousand |
| Deferred income taxes | - | - | -4.15 Million | -853 Thousand | - | -756 Thousand |
| Stock-based compensation | 12.71 Million | 12.83 Million | 13.88 Million | 54.82 Million | 13.86 Million | 13.34 Million |
| Change in working capital | 14.09 Million | -16.3 Million | 10.26 Million | 5.86 Million | 4.77 Million | -5.16 Million |
| Other non-cash items | 27.56 Million | -30.16 Million | -10 Thousand | 23.14 Million | -2.11 Million | 25.52 Million |
| Investing Cash Flow | 34.49 Million | 61.54 Million | -42.06 Million | -44.45 Million | -117.45 Million | 72.93 Million |
| Investments in PPE | -181 Thousand | -40 Thousand | -173 Thousand | -583 Thousand | -91 Thousand | -319 Thousand |
| Acquisitions | 65 Thousand | - | 41.88 Thousand | 43.87 Thousand | 117.36 Thousand | -73.25 Thousand |
| Investment purchases | -19.39 Million | -10.11 Million | -95.98 Million | -549.18 Million | -264.11 Million | -125.2 Million |
| Sales/Maturities of investments | 54 Million | 71.7 Million | 54.1 Million | 505.3 Million | 146.75 Million | 198.45 Million |
| Other Investing Activities | 65 Thousand | 61.58 Million | -41.88 Thousand | -43.87 Thousand | -117.36 Thousand | 73.25 Thousand |
| Financing Cash Flow | 9000.00 | 7000.00 | - | 237.3 Million | 309 Thousand | 236.62 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -241 Thousand | - | - | - | - |
| Common Stock Issuance | 9000.00 | 248 Thousand | -235.68 Million | 237.3 Million | 309 Thousand | 236.62 Million |
| Other Financing Activities | - | -241 Thousand | 235.44 Million | 237.3 Million | 309 Thousand | 236.62 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 11.79 Million | -15.24 Million | 10.39 Million | 10.91 Million | 6.32 Million | -4.39 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.3 Million | -1.05 Million | -129 Thousand | -5.05 Million | -1.54 Million | -770 Thousand |
| Cash at beginning of period | 37.61 Million | 28.03 Million | 110.75 Million | 43.06 Million | 269.18 Million | 38.9 Million |
| Cash at end of period | 36.97 Million | 37.61 Million | 28.03 Million | 28.03 Million | 113.37 Million | 269.18 Million |
| Capital Expenditure | -181 Thousand | -40 Thousand | -173 Thousand | -583 Thousand | -91 Thousand | -319 Thousand |
| Effect of forex changes on cash | - | - | - | -54 Thousand | - | - |
| Net cash flow / Change in cash | -640 Thousand | 9.57 Million | -82.71 Million | -15.03 Million | -155.8 Million | 230.27 Million |
| Free Cash Flow | -35.32 Million | -52.01 Million | -40.77 Million | -208.4 Million | -38.75 Million | -79.59 Million |
AUOTY
KNX
TWMIF
NVA
9824
QBR-A